RXSIGHT INC's ticker is and the CUSIP is 78349D107. A total of 54 filers reported holding RXSIGHT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,192 | -3.2% | 8,397 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $241,834 | -34.2% | 8,397 | -61.9% | 0.00% | -20.0% |
| Q1 2023 | $367,460 | +31.6% | 22,030 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $279,120 | +111.5% | 22,030 | +100.0% | 0.00% | +100.0% |
| Q3 2022 | $132,000 | -47.4% | 11,015 | -45.7% | 0.00% | -33.3% |
| Q1 2022 | $251,000 | – | 20,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
| Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
| Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
| RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
| EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
| No Street GP LP | 250,000 | $6,972,500 | 0.83% |
| ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
| Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
| Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |